SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 12,458.23 |
| Enterprise Value ($M) | 21,674.29 |
| Book Value ($M) | 10,084.29 |
| Book Value / Share | 22.58 |
| Price / Book | 1.24 |
| NCAV ($M) | -5,023.37 |
| NCAV / Share | -11.25 |
| Price / NCAV | -2.48 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.07 |
| Return on Assets (ROA) | 0.07 |
| Return on Equity (ROE) | 0.12 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.90 |
| Current Ratio | 7.90 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,274.19 |
| Assets | 16,381.85 |
| Liabilities | 6,297.56 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2,354.55 |
| Operating Income | 1,492.15 |
| Net Income | 1,134.83 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 2,987.80 |
| Cash from Investing | -2,072.79 |
| Cash from Financing | -2,148.75 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 8.54 | 6.65 | |
| 13G/A | General Atlantic Llc | 5.60 | 0.05 | |
| 13G/A | Fmr Llc | 7.10 | -28.40 | |
| 13G/A | Morgan Stanley | 9.20 | -5.98 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 185,885 | 1,424,453 | 13.05 | |
| 356,254 | 1,806,173 | 19.72 | |
| 313,908 | 1,945,645 | 16.13 | |
| 282,287 | 862,049 | 32.75 | |
| 405,744 | 971,708 | 41.76 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RLMD – Relmada Therapeutics, Inc. | RLYB – Rallybio Corporation |
| ROIV – Roivant Sciences Ltd. | RPTX – Repare Therapeutics Inc. |
| RVMD – Revolution Medicines, Inc. |
Financial data and stock pages provided by
Fintel.io